Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome (TOPIC)

Hôpital de la Timone

Status: Unknown

Conditions: Acute Coronary Syndrome; Antiplatelet Therapy; Coronary Stenting

Study type: Observational

Funder types: Other

Identifiers

NCT02099422

APHM-011

2013-A01168-37 (Other Identifier)

Details and patient eligibility

About

Comparison of two antiplatelet strategies between months 1 and 12 after coronary stenting for ACS. Efficiency and tolerance évaluation

Enrollment: 500 estimated patients

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ACS and coronary stenting one month ago

Exclusion criteria

• age under 18 and pregnancy